Two-Center, Randomized, Placebo and Active Comparator Evaluation of the Pharmacokinetics (PK) and Safety, Along with Initial Pharmacodynamic (PD) Efficacy of Three Dose Levels of TBS-2 Intranasal Gel Applied Twice-Daily (BID) for up to Three Days in Female Subjects with Hypoactive Sexual Desire Disorder (HSDD) or Anorgasmia (ANOR).

Trial Profile

Two-Center, Randomized, Placebo and Active Comparator Evaluation of the Pharmacokinetics (PK) and Safety, Along with Initial Pharmacodynamic (PD) Efficacy of Three Dose Levels of TBS-2 Intranasal Gel Applied Twice-Daily (BID) for up to Three Days in Female Subjects with Hypoactive Sexual Desire Disorder (HSDD) or Anorgasmia (ANOR).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Anorgasmia; Decreased libido
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top